|
1
|
Elbashir AA and Aboul-Enein HY: Separation
and analysis of triazine herbcide residues by capillary
electrophoresis. Biomed Chromatogr. 29:835–842. 2015. View Article : Google Scholar
|
|
2
|
Silva M and Iyer P: Toxicity endpoint
selections for a simazine risk assessment. Birth Defects Res B Dev
Reprod Toxicol. 101:308–324. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Salvestrini S, Canzano S, Iovino P, Leone
V and Capasso S: Modelling the biphasic sorption of simazine,
imidacloprid, and boscalid in water/soil systems. J Environ Sci
Health B. 49:578–590. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Brevini TA, Zanetto SB and Cillo F:
Effects of endocrine disruptors on developmental and reproductive
functions. Curr Drug Targets Immune Endocr Metabol Disord. 5:1–10.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sannino F, Marocco A, Garrone E, Esposito
S and Pansini M: Adsorption of simazine on zeolite H-Y and sol-gel
technique manufactured porous silica: a comparative study in model
and natural waters. J Environ Sci Health B. 50:777–787. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wan R, Yang Y, Sun W, Wang Z and Xie S:
Simazine biodegradation and community structures of
ammonia-oxidizing microorganisms in bioaugmented soil: impact of
ammonia and nitrate nitrogen sources. Environ Sci Pollut Res Int.
21:3175–3181. 2014. View Article : Google Scholar
|
|
7
|
Wan R, Wang Z and Xie S: Dynamics of
communities of bacteria and ammonia-oxidizing microorganisms in
response to simazine attenuation in agricultural soil. Sci Total
Environ. 472:502–508. 2014. View Article : Google Scholar
|
|
8
|
Velisek J, Stara A, Machova J, Dvorak P,
Zuskova E and Svobodova Z: Effects of low-concentrations of
simazine on early life stages of common carp (Cyprinus carpio L.).
Neuro Endocrinol Lett. 33(Suppl 3): 90–95. 2012.
|
|
9
|
Park S, Kim S, Jin H, Lee K and Bae J:
Impaired development of female mouse offspring maternally exposed
to simazine. Environ Toxicol Pharmacol. 38:845–851. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zorrilla LM, Gibson EK and Stoker TE: The
effects of simazine, a chlorotriazine herbicide, on pubertal
development in the female Wistar rat. Reprod Toxicol. 29:393–400.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bogdanffy MS, O'Connor JC, Hansen JF,
Gaddamidi V, Van Pelt CS, Green JW and Cook JC: Chronic toxicity
and oncogenicity bioassay in rats with the chloro-s-triazine
herbicide cyanazine. J Toxicol Environ Health A. 60:567–586. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim KR, Son EW, Hee-Um S, Kim BO, Rhee DK
and Pyo S: Immune alterations in mice exposed to the herbicide
simazine. J Toxicol Environ Health A. 66:1159–1173. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim KR, Son EW, Rhee DK and Pyo S: The
immunomodulatory effects of the herbicide simazine on murine
macrophage functions in vitro. Toxicol In Vitro. 16:517–523. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ren R, Sun DJ, Yan H, Wu YP and Zhang Y:
Oral exposure to the herbicide simazine induces mouse spleen
immunotoxicity and immune cell apoptosis. Toxicol Pathol. 41:63–72.
2013. View Article : Google Scholar
|
|
15
|
Sai L, Liu Y, Qu B, Yu G, Guo Q, Bo C, Xie
L, Jia Q, Li Y, Li X, et al: The effects of simazine, a
chlorotriazine herbicide, on the expression of genes in developing
male Xenopus laevis. Bull Environ Contam Toxicol. 95:157–163. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yu J, Li X, Yang J, Wu Y and Li B: Effects
of simazine exposure on neuronal development-related factors in
MN9D cells. Med Sci Monit. 22:2831–2838. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yamaguchi Y, Lee YA and Goto Y: Dopamine
in socioecological and evolutionary perspectives: implications for
psychiatric disorders. Front Neurosci. 9:2192015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Krabbe S, Duda J, Schiemann J, Poetschke
C, Schneider G, Kandel ER, Liss B, Roeper J and Simpson EH:
Increased dopamine D2 receptor activity in the striatum alters the
firing pattern of dopamine neurons in the ventral tegmental area.
Proc Natl Acad Sci USA. 112:E1498–E1506. 2015.PubMed/NCBI
|
|
19
|
Chastain LG, Qu H, Bourke CH, Iuvone PM,
Dobner PR, Nemeroff CB and Kinkead B: Striatal dopamine receptor
plasticity in neurotensin deficient mice. Behav Brain Res.
280:160–171. 2015. View Article : Google Scholar :
|
|
20
|
Yuan JS, Reed A, Chen F and Stewart CN Jr:
Statistical analysis of real-time PCR data. BMC Bioinformatics.
7:852006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ojha S, Javed H, Azimullah S, Abul Khair
SB and Haque ME: Neuroprotective potential of ferulic acid in the
rotenone model of Parkinson's disease. Drug Des Devel Ther.
9:5499–5510. 2015.PubMed/NCBI
|
|
22
|
Tsai EM, Wang YC, Lee TT, Tsai CF, Chen
HS, Lai FJ, Yokoyama KK, Hsieh TH, Wu RM and Lee JN: Dynamic Trk
and G protein signalings regulate dopaminergic neurodifferentiation
in human trophoblast stem cells. PLoS One. 10:e01438522015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kitao Y, Ageta-Ishihara N, Takahashi R,
Kinoshita M and Hori O: Transgenic supplementation of SIRT1 fails
to alleviate acute loss of nigrostriatal dopamine neurons and
gliosis in a mouse model of MPTP-induced parkinsonism. F1000Res.
4:1302015.PubMed/NCBI
|
|
24
|
Gomes FV, Guimarães FS and Grace AA:
Effects of pubertal cannabinoid administration on attentional
set-shifting and dopaminergic hyper-responsivity in a developmental
disruption model of schizophrenia. Int J Neuropsychopharmacol.
18:2014.PubMed/NCBI
|
|
25
|
Koblinger K, Füzesi T, Ejdrygiewicz J,
Krajacic A, Bains JS and Whelan PJ: Characterization of A11 neurons
projecting to the spinal cord of mice. PloS One. 9:e1096362014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Del Pino J, Moyano P, Ruiz M, Anadón MJ,
Diaz MJ, García JM, Labajo-González E and Frejo MT: Amitraz changes
NE, DA and 5-HT biosynthesis and metabolism mediated by alterations
in estradiol content in CNS of male rats. Chemosphere. 181:518–529.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Maasz G, Zrinyi Z, Reglodi D, Petrovics D,
Rivnyak A, Kiss T, Jungling A, Tamas A and Pirger Z: Pituitary
adenylate cyclase-activating polypeptide (PACAP) has a
neuroprotective function in dopamine-based neurodegeneration in rat
and snail parkinsonian models. Dis Model Mech. 10:127–139. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang M: Two-step production of monoamines
in monoenzymatic cells in the spinal cord: a different control
strategy of neurotransmitter supply? Neural Regen Res.
11:1904–1909. 2016. View Article : Google Scholar
|
|
29
|
Keber U, Klietz M, Carlsson T, Oertel WH,
Weihe E, Schäfer MK, Höglinger GU and Depboylu C: Striatal tyrosine
hydroxylase-positive neurons are associated with L-DOPA-induced
dyskinesia in hemiparkinsonian mice. Neuroscience. 298:302–317.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sathiakumar N, MacLennan PA, Mandel J and
Delzell E: A review of epidemiologic studies of triazine herbicides
and cancer. Crit Rev Toxicol. 41(Suppl 1): 1–34. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li Y, Sun Y, Yang J, Wu Y, Yu J and Li B:
The long-term effects of the herbicide atrazine on the dopaminergic
system following exposure during pubertal development. Mutat Res
Genet Toxicol Environ Mutagen. 763:23–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rodríguez-Traver E, Solís O, Díaz-Guerra
E, Ortiz Ó, Vergaño-Vera E, Méndez-Gómez HR, García-Sanz P,
Moratalla R and Vicario-Abejón C: Role of Nurr1 in the generation
and differentiation of dopaminergic neurons from stem cells.
Neurotox Res. 30:14–31. 2016. View Article : Google Scholar
|
|
33
|
Hammond SL, Safe S and Tjalkens RB: A
novel synthetic activator of Nurr1 induces dopaminergic gene
expression and protects against 6-hydroxydopamine neurotoxicity in
vitro. Neurosci Lett. 607:83–89. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Smidt MP, Smits SM and Burbach JP:
Molecular mechanisms underlying midbrain dopamine neuron
development and function. Eur J Pharmacol. 480:75–88. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Decressac M, Volakakis N, Björklund A and
Perlmann T: NURR1 in Parkinson disease - from pathogenesis to
therapeutic potential. Nat Rev Neurol. 9:629–636. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hwang DY, Hong S, Jeong JW, Choi S, Kim H,
Kim J and Kim KS: Vesicular monoamine transporter 2 and dopamine
transporter are molecular targets of Pitx3 in the ventral midbrain
dopamine neurons. J Neurochem. 111:1202–1212. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jiang C, Wan X, He Y, Pan T, Jankovic J
and Le W: Age-dependent dopaminergic dysfunction in Nurr1 knockout
mice. Exp Neurol. 191:154–162. 2005. View Article : Google Scholar
|
|
38
|
Semchuk KM, Love EJ and Lee RG:
Parkinson's disease and exposure to agricultural work and pesticide
chemicals. Neurology. 42:1328–1335. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Priyadarshi A, Khuder SA, Schaub EA and
Shrivastava S: A meta-analysis of Parkinson's disease and exposure
to pesticides. Neurotoxicology. 21:435–440. 2000.PubMed/NCBI
|
|
40
|
Sun Y, Li YS, Yang JW, Yu J, Wu YP and Li
BX: Exposure to atrazine during gestation and lactation periods:
toxicity effects on dopaminergic neurons in offspring by
downregulation of Nurr1 and VMAT2. Int J Mol Sci. 15:2811–2825.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hermanson E, Joseph B, Castro D, Lindqvist
E, Aarnisalo P, Wallén A, Benoit G, Hengerer B, Olson L and
Perlmann T: Nurr1 regulates dopamine synthesis and storage in MN9D
dopamine cells. Exp Cell Res. 288:324–334. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Smits SM, Ponnio T, Conneely OM, Burbach
JP and Smidt MP: Involvement of Nurr1 in specifying the
neurotransmitter identity of ventral midbrain dopaminergic neurons.
Eur J Neurosci. 18:1731–1738. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Miller GW, Erickson JD, Perez JT, Penland
SN, Mash DC, Rye DB and Levey AI: Immunochemical analysis of
vesicular monoamine transporter (VMAT2) protein in Parkinson's
disease. Exp Neurol. 156:138–148. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lu W and Wolf ME: Expression of dopamine
transporter and vesicular monoamine transporter 2 mRNAs in rat
midbrain after repeated amphetamine administration. Brain Res Mol
Brain Res. 49:137–148. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Fornai F, Battaglia G, Gesi M, Giorgi FS,
Orzi F, Nicoletti F and Ruggieri S: Time-course and dose-response
study on the effects of chronic L-DOPA administration on striatal
dopamine levels and dopamine transporter following MPTP toxicity.
Brain Res. 887:110–117. 2000. View Article : Google Scholar
|
|
46
|
Miller GW, Staley JK, Heilman CJ, Perez
JT, Mash DC, Rye DB and Levey AI: Immunochemical analysis of
dopamine transporter protein in Parkinson's disease. Ann Neurol.
41:530–539. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Jaakkola E, Joutsa J and Kaasinen V:
Predictors of normal and abnormal outcome in clinical brain
dopamine transporter imaging. J Neural Transm (Vienna).
123:205–209. 2016. View Article : Google Scholar
|
|
48
|
Choi WS, Kim HW and Xia Z: JNK inhibition
of VMAT2 contributes to rotenone-induced oxidative stress and
dopamine neuron death. Toxicology. 328:75–81. 2015. View Article : Google Scholar :
|
|
49
|
Lohr KM and Miller GW: VMAT2 and
Parkinson's disease: harnessing the dopamine vesicle. Expert Rev
Neurother. 14:1115–1117. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Hall FS, Itokawa K, Schmitt A, Moessner R,
Sora I, Lesch KP and Uhl GR: Decreased vesicular monoamine
transporter 2 (VMAT2) and dopamine transporter (DAT) function in
knockout mice affects aging of dopaminergic systems.
Neuropharmacology. 76(Pt A): 146–155. 2014. View Article : Google Scholar
|
|
51
|
Caronti B, Antonini G, Calderaro C,
Ruggieri S, Palladini G, Pontieri FE and Colosimo C: Dopamine
transporter immunore-activity in peripheral blood lymphocytes in
Parkinson's disease. J Neural Transm Vienna. 108:803–807. 2001.
View Article : Google Scholar
|
|
52
|
Helman G, Pappa MB and Pearl PL: Widening
phenotypic spectrum of AADC deficiency, a disorder of dopamine and
serotonin synthesis. JIMD Rep. 17:23–27. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Helman G, Pappa MB and Pearl PL: Erratum
to: widening phenotypic spectrum of AADC deficiency, a disorder of
dopamine and serotonin synthesis. JIMD Rep. 17:972014. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Hwu WL, Lee NC, Chien YH, Muramatsu S and
Ichinose H: AADC deficiency: occurring in humans, modeled in
rodents. Adv Pharmacol. 68:273–284. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Shih DF, Hsiao CD, Min MY, Lai WS, Yang
CW, Lee WT and Lee SJ: Aromatic L-amino acid decarboxylase (AADC)
is crucial for brain development and motor functions. PLoS One.
8:e717412013. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Duan CL, Su Y, Zhao CL, Lu LL, Xu QY and
Yang H: The assays of activities and function of TH, AADC, and GCH1
and their potential use in ex vivo gene therapy of PD. Brain Res
Brain Res Protoc. 16:37–43. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Witte AV and Flöel A: Effects of COMT
polymorphisms on brain function and behavior in health and disease.
Brain Res Bull. 88:418–428. 2012. View Article : Google Scholar
|
|
58
|
Twamley EW, Hua JP, Burton CZ, Vella L,
Chinh K, Bilder RM and Kelsoe JR: Effects of COMT genotype on
cognitive ability and functional capacity in individuals with
schizophrenia. Schizophr Res. 159:114–117. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
van Amelsvoort T, Zinkstok J, Figee M,
Daly E, Morris R, Owen MJ, Murphy KC, De Haan L, Linszen DH, Glaser
B, et al: Effects of a functional COMT polymorphism on brain
anatomy and cognitive function in adults with velo-cardio-facial
syndrome. Psychol Med. 38:89–100. 2008. View Article : Google Scholar
|
|
60
|
Dorszewska J, Prendecki M, Oczkowska A,
Rozycka A, Lianeri M and Kozubski W: Polymorphism of the COMT, MAO,
DAT, NET and 5-HTT genes, and biogenic amines in Parkinson's
disease. Curr Genomics. 14:518–533. 2013. View Article : Google Scholar
|
